Hemostasis as an optimal system

Mathematical Biosciences

Volumn 204, Issue 2, 2006, Pages 167-184

  Tyurin, Kirill V ^a   Khanin, Mikhail A ^a  

^a CENTER FOR THEORETICAL PROBLEMS OF PHYSICOCHEMICAL PHARMACOLOGY   (Russian Federation)

Author keywords

Constrained optimization techniques; Minimal protein consumption; Optimal clotting factor concentrations

Indexed keywords

BIOCHEMISTRY; BIOMEDICAL ENGINEERING; LAGRANGE MULTIPLIERS; OPTIMAL CONTROL SYSTEMS; OPTIMIZATION; PHYSIOLOGY; PLASMAS; PROBLEM SOLVING;

CONSTRAINED OPTIMIZATION TECHNIQUES; MINIMAL PROTEIN CONSUMPTION; OPTIMAL CLOTTING FACTOR CONCENTRATIONS;

PROTEINS;

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; ENZYME PRECURSOR; PROTHROMBIN;

BIOCHEMISTRY; COAGULATION; ENZYME; OPTIMIZATION;

ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; BLOOD LEVEL; HEMOSTASIS; PHYSIOLOGY; PROTEIN INTAKE; THROMBIN TIME;

ALGORITHMS; BLOOD COAGULATION; BLOOD COAGULATION FACTOR INHIBITORS; BLOOD COAGULATION FACTORS; BLOOD PROTEINS; ENERGY METABOLISM; ENZYME PRECURSORS; HEMOSTASIS; HUMANS; KINETICS; MODELS, BIOLOGICAL;

EID: 33750695303     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mbs.2006.09.005     Document Type: Article

References (64)

1. Gringeri A., and Mannucci P.M. Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors. Haemophilia 11 6 (2005) 611
2. Stassen J.M., Arnout J., and Deckmyn H. The hemostatic system. Curr. Med. Chem. 11 17 (2004) 2245
3. Walsh P.N., and Ahmad S.S. Proteases in blood clotting. Essays Biochem. 38 (2002) 95
4. Amour A., Bird M., Chaudry L., Deadman J., Hayes D., and Kay C. General considerations for proteolytic cascades. Biochem. Soc. Trans. 32 Pt. 1 (2004) 15
5. Hess W.R. Das prinzip des kleinsten kraftverbrauches im dienste hamodynamischer forschung. Arch. Anat. Physiol. 2 (1914) 1
6. Murray C. The physiological principle of minimum work I: the vascular system and the cost of blood volume. Proc. Natl. Acad. Sci. USA 12 (1926) 207
7. Cohn D. Optimal systems I: the vascular system. Bull. Math. Biophys. 16 (1955) 59
8. Cohn D. Optimal systems II: the vascular system. Bull. Math. Biophys. 17 (1955) 219
9. Chernousko F.L. Optimal branching tree structures. Appl. Math. Mech. USSR 41 (1977) 376
10. Kamiya A., and Togawa T. Optimal branching structure of the vascular tree. Bull. Math. Biophys. 34 (1972) 431
11. Khanin M.A., and Bukharov I.B. Optimal structure of the microcirculatory bed. J. Theor. Biol. 169 (1991) 267
12. Horsfield K., and Cummings G. Angles of branching and diameters of branches in the human bronchial tree. Bull. Math. Biophys. 29 (1967) 245
13. Zamir M. Optimality principles in arterial branching. J. Theor. Biol. 62 (1976) 227
14. Uylings H.B.M. Optimization of diameters and bifurcation angles in lung and vascular tree structures. Bull. Math. Biol. 39 (1977) 509
15. Otis A.B., Fenn W.O., and Rahn N. Mechanics of breathing in man. J. Appl. Physiol. 2 (1950) 592
16. Khanin M., and Bukharov I. Mathematical model of the pathological functional state of the oxygen transport system. J. Theor. Biol. 46 (1984) 115
17. Khanin M., and Bukharov I. Mathematical model of the exercise functional state of the oxygen transport system. J. Theor. Biol. 137 (1989) 191
18. Fisher R.A. The Genetic Theory of Natural Selection (1930), Clarendon, New York
19. Khanin M.A., and Dorfman N.L. Mathematical model of growth, based on the evolutionary extremal principle. Dokl. Akad. Nauk SSSR 212 3 (1973) 743
20. Rosen R. Optimality Principles in Biology (1967), Butterworths, London
21. Tyurin K.V., and Khanin M.A. Optimality principle and determination of kinetic constants for biochemical reactions. Math. Med. Biol. 22 1 (2005) 1
22. Macfarlane R.G. An enzyme cascade in the blood coagulation mechanism, and its function as a biochemical amplifier. Nature 202 (1964) 498
23. Davie E.W., and Ratnoff O.D. Waterfall sequence of intrinsic blood coagulation. Science 145 (1964) 1310
24. Levine S.N. Enzyme amplifier kinetics. Science 152 (1966) 651
25. Tracy P.B., Eide L.L., and Mann K.G. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations. J. Biol. Chem. 260 (1985) 2119
26. Monkovic D.D., and Tracy P.B. Activation of human factor V by factor Xa and thrombin. Biochemistry 29 (1990) 1118
27. Esmon C.T. The protein C pathway. Crit. Care Med. 28 (2000) 44
28. Bauer K., Kass B.L., Ten Cate H., Bednarek M.A., Hawinger J.J., and Rosenberg R.D. Detection in factor X activation in humans. Blood 74 (1989) 2007
29. Wildgoose P., Nemerson J., Lyng-Hansen L., Nielsen F.E., Glaser S., and Hedner U. Measurement of basal levels of factor VIIa in haemophilia A & B patients. Blood 80 (1992) 25
30. Morrissay J.H., Macik B.G., Neuenschwander P.F., and Comp P.C. Quantification of factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 81 (1993) 737
31. Obraztsov I.F., Kardakov D.V., Kogan A.E., and Khanin M.A. A mathematical model of the background state of the blood coagulation system. Proc. Russ. Acad. Sci. Ser. Biochem. Biophys. 376 (2001) 10
32. Baglia F.A., and Walsh P.N. Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa. J. Biol. Chem. 275 27 (2000) 20514
33. 2+ on the kinetic parameters of the activation of factor IX by factor XI. J. Biol. Chem. 257 (1982) 4127
34. Warn-Cramer B.J., and Bajaj S.P. Intrinsic versus extrinsic coagulation: kinetic consideration. Biochemistry 22 (1986) 757
35. Sinha D., Seaman F.S., and Walsh P.N. Role of calcium ions and the chain of factor XIa in the activation of human coagulation factor IX. Biochemistry 26 (1987) 3768
36. Soons H., Janssen-Claessen T., Hemker H.C., and Tans G. The effect of platelets in the activation of human blood coagulation factor IX by factor XIa. Blood 68 (1986) 140
37. Walsh P.N., Bradford H., Sinha D., Piperno J.R., and Tuszunski G.P. Kinetics of the factor XIa catalyzed activation of human blood coagulation factor IX. J. Clin. Invest. 73 (1984) 1392
38. Komiyama Y., Pedersen A.H., and Kisiel W. Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids and tissue factor. Biochemistry 29 40 (1990) 9418
39. 2+, phospholipids and tissue factor apoprotein to the activation of human blood coagulation factor X by activated factor VII. Biochem. J. 265 2 (1990) 327
40. Hultin M.B. Role of human factor VIII in factor X activation. J. Clin. Invest. 69 (1982) 950
41. Mertens K., van Wijnagaarden A., and Bertina R.M. The role of factor VIII in the activation of human blood coagulation factor X by activated factor XI. Thromb. Haemost. 54 (1985) 654
42. Rawala-Sheikh R., Ahmad S.S., Ashby B., and Walsh P.N. Kinetics of coagulation factor X activation by platelet bound factor IXa. Biochemistry 29 (1990) 2606
43. Rosing J., Tans G., Govers-Riemslag J.W.P., Zwaal R.F.A., and Hemker H.C. The role of phospholipids and factor Va in the prothrombinase complex. J. Biol. Chem. 255 (1980) 274
44. Krishnaswamy S., Church W.R., Nesheim M.E., and Mann K.G. Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism. J. Biol. Chem. 262 (1987) 3291
45. Matsushita T., Kojima T., Emi N., Takahashi I., and Saito H. Impaired human tissue factor mediated activity in blood clotting factor VII (Arg304-Trp). Evidence that a region in the catalytic domain of factor VII is important for the association with tissue factor. J. Biol. Chem. 269 10 (1994) 2649
46. Hill-Eubanks D.S., and Lollar P. Von Willebrand factor is a cofactor for thrombin-catalysed cleavage of the factor VIII light chain. J. Biol. Chem. 265 (1990) 17854
47. Bonniec B.F., Guinto E.R., MacGillivray R.T., Stone S.R., and Esmon C.T. The role of thrombin's Tyr-Pro-Pro-Trp in the interaction with fibrinogen, thrombomodulin, protein C, antithrombin III, and the Kunitz inhibitors. J. Biol. Chem. 268 (1993) 19055
48. Solymoss S., Tucker M.M., and Tracy P.B. Kinetics of inactivation of membrane-bound factor Va by activated protein C. Protein S modulates factor Xa protection. J. Biol. Chem. 263 (1988) 14884
49. Gailani D., and Broze G.J. Factor XI activation in a revised model of blood coagulation. Science 253 (1991) 909
50. Willems G., Lindhout T., Hermens W., and Hemker H. Simulation model for thrombin generation in plasma. Haemostasis 21 (1991) 197
51. Bjorkquist P., and Bostrom S. Determination of the kinetic constants of tissue factor/factor VII/factor VIIa and antithrombin/heparin using surface plasmon resonance. Thromb. Res. 85 (1997) 225
52. Jesty J., Wun T.C., and Lorenz A. Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin. Biochemistry 33 42 (1994) 12686
53. Lawson J.H., Butenas S., Ribarik N., and Mann K.G. Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. J. Biol. Chem. 268 (1993) 767
54. Jordan R.E., Oosta G.M., Gardner W.T., and Rosenberg R.D. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin. J. Biol. Chem. 255 (1980) 10081
55. Downing M.R., Bloom J.W., and Mann K.G. Comparison of the inhibition of thrombin by three plasma protease inhibitors. Biochemistry 17 (1978) 2649
56. Lau H.K., and Rosenberg R.D. The isolation and characterization of a specific antibody population directed against the thrombin-antithrombin complex. J. Biol. Chem. 255 (1980) 5885
57. Beatty K., Bieth J., and Travis J. Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J. Biol. Chem. 255 (1980) 3931
58. Rezaie A.R., Cooper S.T., Church F.S., and Esmon C.T. Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. J. Biol. Chem. 270 (1995) 25336
59. Ellis V., Scully M.F., and Kakkar V.V. Inhibition of prothrombinase complex by plasma proteinase inhibitors. Biochemistry 23 (1984) 5882
60. Scott C.F., Schapira M., James H.L., Cohen A.P., and Colman R.W. Inactivation of factor XIa by plasma protease inhibitors: pre-dominant role of alfa1-protease inhibitor and protective effect of HMWK. J. Clin. Invest. 69 4 (1982) 844
61. Berrettini M., Schleef R.R., Espana F., Loskutoff D.J., and Griffin J.H. Interaction of type 1 plasminogen activator inhibitor with the enzymes of the contact activation system. J. Biol. Chem. 264 20 (1989) 11738
62. Suzuki K., Nishioka J., Kusumoto H., and Hashimoto H. Mechanism of inhibition of activated protein C by protein C inhibitor. J. Biochem. 95 (1984) 187
63. Heeb M.J., and Griffin J.H. Physiologic inhibition of human activated protein C by a1-antitrypsin. J. Biol. Chem. 263 (1988) 11613
64. Butenas S., vant Veer C., and Mann K.G. Normal thrombin generation. Blood 94 (1999) 2169